De-licensing of five bulk drugs

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

..... ensing for all bulk drugs and their formulations and for intermediates stands abolished except for the five bulk drugs (reserved for the Public Sector under the Drug Policy) and products produced by re-combinant DNA technology. This had been given wide publicity vide Press Note No.4(1994 Series) dated 25.10.94 issued by the Ministry of Industry. As an ongoing process of industrial reforms, Governm .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

..... use of re-combinant DNA technology and bulk drugs requiring in vivo use of nucleic acid as the active principles (items not classified under Harmonised System) and formulations based on use of specific cell or tissue targeted formulations (item not classified under Harmonised System) shall continue to remain under compulsory licensing. 4. The entrepreneurs who wish to avail themselves of the de .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X